Preventing frailty in people living with HIV aged 65–74
A Pilot Project for PLWH Aged 65-75: Preventing the Development of Frailty
This project will see if using the Fried frailty screen and offering a linked care pathway can identify and help prevent frailty in people living with HIV aged 65–74.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 100 (estimated) |
| Ages | 65 Years to 74 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire Saint Pierre Academic / other |
| Locations | 1 site (Brussels) |
| Trial ID | NCT07486661 on ClinicalTrials.gov |
What this trial studies
This observational pilot in Brussels will screen people living with HIV aged 65–74 using the Fried frailty phenotype to determine how many meet criteria for frailty or pre-frailty. Researchers will characterize clinical and social features of participants who screen positive and compare Fried scale results with local clinical judgment to explore validity in this population. The project will also offer a model care pathway for those identified at risk, linking geriatric assessment and management services that are not routinely reimbursed for this age group. No experimental treatments are given; data collection will occur at CHU Saint-Pierre and the centre MIA and results will inform larger preventive programs.
Who should consider this trial
Good fit: People living with HIV aged 65–74 who can attend visits at CHU Saint-Pierre or centre MIA in Brussels and can provide informed consent are ideal candidates.
Not a fit: People younger than 65 or older than 74, those without HIV, those already severely frail beyond preventive interventions, or those unable to attend the Brussels sites are unlikely to benefit.
Why it matters
Potential benefit: If successful, the project could enable earlier identification and a practical care pathway to prevent or delay frailty, reducing hospitalizations and preserving independence for older people living with HIV.
How similar studies have performed: The Fried frailty phenotype is widely used and has been applied in older and some HIV-positive cohorts, but targeted validation and prevention pathway work specifically for PLWH aged 65–74 is limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * living with HIV * between 65-74 years Exclusion Criteria: * none
Where this trial is running
Brussels
- CHU Saint-Pierre, centre MIA — Brussels, Belgium (Recruiting)
Study contacts
- Study coordinator: Agnes LIBOIS, MD
- Email: maladiesinfectieuses@stpierre-bru.be
- Phone: +3225354130
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.